Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 124 JPY -1.12% Market Closed
Market Cap: 32.5B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Net Income (Common)
ÂĄ3.2B
CAGR 3-Years
-12%
CAGR 5-Years
-2%
CAGR 10-Years
6%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
ÂĄ149.9B
CAGR 3-Years
-30%
CAGR 5-Years
19%
CAGR 10-Years
4%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
ÂĄ229.1B
CAGR 3-Years
42%
CAGR 5-Years
15%
CAGR 10-Years
13%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
ÂĄ126.8B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
ÂĄ387B
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
ÂĄ54.6B
CAGR 3-Years
-18%
CAGR 5-Years
-25%
CAGR 10-Years
-6%

See Also

What is Daito Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
3.2B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Net Income (Common) amounts to 3.2B JPY.

What is Daito Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%

Over the last year, the Net Income (Common) growth was -3%. The average annual Net Income (Common) growth rates for Daito Pharmaceutical Co Ltd have been -12% over the past three years , -2% over the past five years , and 6% over the past ten years .

Back to Top